The Law of Unintended Consequences, a term popularized in the 20th century by American sociologist Robert K. Mertony, can be defined as a perverse effect contrary to what was originally intended. This can be encountered in medicine when well-meaning regulations and actions "backfire" leading to an undesired result.
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One example would be the emphasis that was directed toward pain management in hospitalized patients over the past several decades. Patient satisfaction surveys conducted in the 1970s revealed that pain was underappreciated and undertreated, resulting in significant patient distress and dissatisfaction. 1 Possible reasons for undertreatment were many, but a commonly cited one by physicians was the concern about causing addiction. The adverse publicity generated by this undertreatment became a major issue for the health-care industry and, supported by a major article that cited a low risk for addiction in cancer patients, 2 physicians began routinely prescribing opioids for chronic noncancer pain. Essentially a "war" on pain was launched, replete with new scoring systems, institutional grades for pain, regulatory standards, 3, 4 and most importantly, new opiate formulations that proved to be powerfully addictive. Physicians responded to the public and regulatory pressure by learning how to concentrate on managing pain as a unique and different entity, the fifth vital sign, and opioids for chronic pain became the standard of care. The intended result of all this activity was better treatment of pain and greater patient satisfaction, which has been difficult to measure and quantify. The unintended perverse consequence has been the well quantified and measured increase in unintentional overdoses. The Centers for Disease Control and Prevention has documented how unintentional deaths from drug overdoses has risen in the United States since the 1990s, with the deaths from prescribed opioid overdoses accounting for more than the ones related to heroin and cocaine combined. 5 We are now in the midst of an opioid epidemic, and the entire healthcare apparatus is scrambling to find appropriate regulatory and safety solutions.
Our recent practice experience at an urban, academic medical center leads us to believe that we are now facing another potential unintended consequence of well-meaning regulation. The Centers of Medicare and Medicaid Services (CMS) implemented the Hospital Consumer Assessment of Healthcare Providers and Systems survey (HCAHPS), a scoring system for hospital inpatients based on 27 categories of care and communication, with the goal of creating incentives for hospitals to improve the quality and transparency of care, based on public reporting of results. The HCAPHS score is incorporated with quality measures, and better-performing hospitals are rewarded by a value-based incentive provided by CMS, which for 2017 is in the form of a partial or total repayment of an initial 2% withhold of reimbursement.
Two of the quality measures that are used are rates of catheter-associated urinary tract infection (CAUTI) and central line-associated blood stream infections (CLABSI). By mandating public reporting of these figures and basing full reimbursement upon them, CMS's intended consequence was for institutions to improve patient care and safety by continuously lowering their hospital-acquired infection rates. In fact, emphasis on these measures has undeniably increased, and almost every institution has embraced best care practices in an attempt to lower CLABSI and CAUTI rates. For CLABSI, this has meant providing more consistent education to the staff regarding the importance of assuring sterile techniques during the placement and maintenance of central venous access, reducing the duration of central venous access whenever it is used, or preferably, avoiding it altogether or using an alternative route whenever possible. At most institutions, these measures have successfully and safely reduced overall hospital-acquired infection rates, but another trend, an unintended and potentially perverse consequence, has also emerged. At our very busy quaternary center, we receive transfers from as many as 22 surrounding hospitals, and we are starting to receive patients who are in shock and arrive with high doses of potent vasoconstrictors infusing through peripheral venous access rather than a central one. We are also increasingly accepting patients in whom a primary reason for transfer is that central access is deemed to be difficult or likely prolonged, placing them at a heightened risk for CLABSI. From what we see, there seems to be a concern in these hospitals, many with a small positive or even zero profit margin, over placing central venous access and incurring the risk of a CLABSI and the resultant negative impact on reimbursement. In this instance, transfer of the patient is guided not by the safety or level of care concerns but by financial considerations.
It is because of these developments that studies like the one authored by Dillon et al (2018) in this issue of JICM take on more importance and significance. In their article, "Incidence of adverse events during peripheral administration of sodium chloride 3%," the authors have concluded that the infusion of hypertonic solution through peripheral veins is well tolerated. The study was a retrospective study that took place in 1 institution and included 66 patients who received sodium chloride 3% through peripheral veins when emergent infusion was required, in order to avoid the delay of placing central venous access. The majority of the patients included in the study received the hypertonic saline for the management of hyponatremia (64%), and the duration and rate of fluid infusion was limited to a relatively short 14 hours. Complications were minimal but the applicability of the study to a broader clinical setting is clearly limited; this study is at least consistent with prior studies and provides some evidence that short-term infusion of hyperosmotic substances can be safely accomplished through a peripheral vein if safety measures are adhered to.
Value-based purchasing was introduced to incentivize institutions to improve patient safety and outcomes, but it is possible that it will lead to an increase in unsafe practices. In our experience, in trying to minimize CLABSI, practitioners are experimenting more with peripheral infusions of agents that traditionally have been given via the central route. This is a generally reasonable response to the issue, especially since many drugs that are recommended to be given via a central line may be safely given peripherally, but there is a paucity of information regarding most of them. Complications from peripheral extravasations of vasoconstrictor drugs and chemotherapeutic agents are well-documented and can be extensive and gruesome, but we expect to see more studies that explore the limits of how, when, and where these agents can be given peripherally. 6 Peripherally inserted central catheters (PICCs) are now extensively used as an alternative to jugular or subclavian catheters, but these lines are still central lines and in our hospital, they have become the most common cause of CLABSIs. We have attempted to introduce a policy that would substitute midline catheters (which are not treated as central) for most PICCs but have been thwarted by a lack of evidence to support what drugs may be safely infused. If we are to fully realize the anticipated advantages of less central lines and CLABSIs, more clinically relevant studies are needed, including ones that investigate improvements in technology that reduce the possibility of extravasation. Until better evidence is available, we recommend limiting the infusion of caustic substances (not including vasopressors or chemotherapeutics) through peripheral catheters to settings similar to those described by Dillon et al-emergent or short-term use, preferably through a 20 gauge or larger antecubital vein catheter established without any issues and maintained using a standard protocol.
